<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">35546635</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>13</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1476-5578</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
              <Day>11</Day>
            </PubDate>
          </JournalIssue>
          <Title>Molecular psychiatry</Title>
          <ISOAbbreviation>Mol Psychiatry</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Rare variants implicate NMDA receptor signaling and cerebellar gene networks in risk for bipolar disorder.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1038/s41380-022-01609-4</ELocationID>
        <Abstract>
          <AbstractText>Bipolar disorder is an often-severe mental health condition characterized by alternation between extreme mood states of mania and depression. Despite strong heritability and the recent identification of 64 common variant risk loci of small effect, pathophysiological mechanisms remain unknown. Here, we analyzed genome sequences from 41 multiply-affected pedigrees and identified variants in 741 genes with nominally significant linkage or association with bipolar disorder. These 741 genes overlapped known risk genes for neurodevelopmental disorders and clustered within gene networks enriched for synaptic and nuclear functions. The top variant in this analysis - prioritized by statistical association, predicted deleteriousness, and network centrality - was a missense variant in the gene encoding D-amino acid oxidase (DAO<sup>G131V</sup>). Heterologous expression of DAO<sup>G131V</sup> in human cells resulted in decreased DAO protein abundance and enzymatic activity. In a knock-in mouse model of DAO<sup>G131</sup>, Dao<sup>G130V/+</sup>, we similarly found decreased DAO protein abundance in hindbrain regions, as well as enhanced stress susceptibility and blunted behavioral responses to pharmacological inhibition of N-methyl-D-aspartate receptors (NMDARs). RNA sequencing of cerebellar tissue revealed that Dao<sup>G130V</sup> resulted in decreased expression of two gene networks that are enriched for synaptic functions and for genes expressed, respectively, in Purkinje neurons or granule neurons. These gene networks were also down-regulated in the cerebellum of patients with bipolar disorder compared to healthy controls and were enriched for additional rare variants associated with bipolar disorder risk. These findings implicate dysregulation of NMDAR signaling and of gene expression in cerebellar neurons in bipolar disorder pathophysiology and provide insight into its genetic architecture.</AbstractText>
          <CopyrightInformation>© 2022. The Author(s), under exclusive licence to Springer Nature Limited.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Hasin</LastName>
            <ForeName>Naushaba</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore, MD, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Riggs</LastName>
            <ForeName>Lace M</ForeName>
            <Initials>LM</Initials>
            <Identifier Source="ORCID">0000-0003-4368-4089</Identifier>
            <AffiliationInfo>
              <Affiliation>Program in Neuroscience and Training Program in Integrative Membrane Biology, University of Maryland School of Medicine, Baltimore, MD, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shekhtman</LastName>
            <ForeName>Tatyana</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Psychiatry, University of California San Diego, La Jolla, CA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ashworth</LastName>
            <ForeName>Justin</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Institute for Systems Biology, Seattle, WA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lease</LastName>
            <ForeName>Robert</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore, MD, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Program in Molecular Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Oshone</LastName>
            <ForeName>Rediet T</ForeName>
            <Initials>RT</Initials>
            <AffiliationInfo>
              <Affiliation>Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore, MD, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Humphries</LastName>
            <ForeName>Elizabeth M</ForeName>
            <Initials>EM</Initials>
            <AffiliationInfo>
              <Affiliation>Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore, MD, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Program in Molecular Epidemiology, University of Maryland School of Medicine, Baltimore, MD, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Badner</LastName>
            <ForeName>Judith A</ForeName>
            <Initials>JA</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Psychiatry, Rush University Medical College, Chicago, IL, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Thomson</LastName>
            <ForeName>Pippa A</ForeName>
            <Initials>PA</Initials>
            <Identifier Source="ORCID">0000-0002-4208-5271</Identifier>
            <AffiliationInfo>
              <Affiliation>Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, Scotland, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Glahn</LastName>
            <ForeName>David C</ForeName>
            <Initials>DC</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Psychiatry, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Craig</LastName>
            <ForeName>David W</ForeName>
            <Initials>DW</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Translational Genomics, University of Southern California, Los Angeles, CA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Edenberg</LastName>
            <ForeName>Howard J</ForeName>
            <Initials>HJ</Initials>
            <Identifier Source="ORCID">0000-0003-0344-9690</Identifier>
            <AffiliationInfo>
              <Affiliation>Departments of Biochemistry and Molecular Biology and Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gershon</LastName>
            <ForeName>Elliot S</ForeName>
            <Initials>ES</Initials>
            <Identifier Source="ORCID">0000-0003-4818-8631</Identifier>
            <AffiliationInfo>
              <Affiliation>Departments of Psychiatry and Human Genetics, University of Chicago, Chicago, IL, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>McMahon</LastName>
            <ForeName>Francis J</ForeName>
            <Initials>FJ</Initials>
            <AffiliationInfo>
              <Affiliation>Intramural Research Program, National Institute of Mental Health, Bethesda, MD, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nurnberger</LastName>
            <ForeName>John I</ForeName>
            <Initials>JI</Initials>
            <Identifier Source="ORCID">0000-0002-7674-1767</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Psychiatry, Indiana University School of Medicine, Indianapolis, IN, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zandi</LastName>
            <ForeName>Peter P</ForeName>
            <Initials>PP</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, Baltimore, MD, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kelsoe</LastName>
            <ForeName>John R</ForeName>
            <Initials>JR</Initials>
            <Identifier Source="ORCID">0000-0002-3013-2333</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Psychiatry, University of California San Diego, La Jolla, CA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Roach</LastName>
            <ForeName>Jared C</ForeName>
            <Initials>JC</Initials>
            <AffiliationInfo>
              <Affiliation>Institute for Systems Biology, Seattle, WA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gould</LastName>
            <ForeName>Todd D</ForeName>
            <Initials>TD</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Departments of Pharmacology and Anatomy and Neurobiology, University of Maryland School of Medicine, Baltimore, MD, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Veterans Affairs Maryland Health Care System, Baltimore, MD, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ament</LastName>
            <ForeName>Seth A</ForeName>
            <Initials>SA</Initials>
            <Identifier Source="ORCID">0000-0001-6443-7509</Identifier>
            <AffiliationInfo>
              <Affiliation>Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore, MD, USA. sament@som.umaryland.edu.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD, USA. sament@som.umaryland.edu.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>R01 MH094483</GrantID>
            <Acronym>MH</Acronym>
            <Agency>NIMH NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 MH110437</GrantID>
            <Acronym>MH</Acronym>
            <Agency>NIMH NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>P50 GM076547</GrantID>
            <Acronym>GM</Acronym>
            <Agency>NIGMS NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>05</Month>
          <Day>11</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Mol Psychiatry</MedlineTA>
        <NlmUniqueID>9607835</NlmUniqueID>
        <ISSNLinking>1359-4184</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>7</Month>
          <Day>19</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>19</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>13</Day>
          <Hour>1</Hour>
          <Minute>59</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35546635</ArticleId>
        <ArticleId IdType="doi">10.1038/s41380-022-01609-4</ArticleId>
        <ArticleId IdType="pii">10.1038/s41380-022-01609-4</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Merikangas KR, Low NCP. The epidemiology of mood disorders. Curr Psychiatry Rep. 2004;6:411–21.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15538988</ArticleId>
            <ArticleId IdType="doi">10.1007/s11920-004-0004-1</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mullins N, Forstner AJ, O’Connell KS, Coombes B, Coleman JRI, Qiao Z, et al. Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology. Nat Genet. 2021;53:817–29.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">34002096</ArticleId>
            <ArticleId IdType="pmc">8192451</ArticleId>
            <ArticleId IdType="doi">10.1038/s41588-021-00857-4</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Georgi B, Craig D, Kember RL, Liu W, Lindquist I, Nasser S, et al. Genomic view of bipolar disorder revealed by whole genome sequencing in a genetic isolate. PLoS Genet. 2014;10:e1004229.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24625924</ArticleId>
            <ArticleId IdType="pmc">3953017</ArticleId>
            <ArticleId IdType="doi">10.1371/journal.pgen.1004229</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ament SA, Szelinger S, Glusman G, Ashworth J, Hou L, Akula N, et al. Rare variants in neuronal excitability genes influence risk for bipolar disorder. Proc Natl Acad Sci USA 2015;112:3576–81.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25730879</ArticleId>
            <ArticleId IdType="pmc">4371952</ArticleId>
            <ArticleId IdType="doi">10.1073/pnas.1424958112</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goes FS, Pirooznia M, Parla JS, Kramer M, Ghiban E, Mavruk S, et al. Exome Sequencing of Familial Bipolar Disorder. JAMA Psychiatry. 2016;73:590–7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27120077</ArticleId>
            <ArticleId IdType="pmc">5600716</ArticleId>
            <ArticleId IdType="doi">10.1001/jamapsychiatry.2016.0251</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cruceanu C, Schmouth JF, Torres-Platas SG, Lopez JP, Ambalavanan A, Darcq E, et al. Rare susceptibility variants for bipolar disorder suggest a role for G protein-coupled receptors. Mol Psychiatry. 2018;23:2050–6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29158579</ArticleId>
            <ArticleId IdType="doi">10.1038/mp.2017.223</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Toma C, Shaw AD, Allcock RJN, Heath A, Pierce KD, Mitchell PB, et al. An examination of multiple classes of rare variants in extended families with bipolar disorder. Transl Psychiatry. 2018;8:65.</Citation>
        </Reference>
        <Reference>
          <Citation>Jia X, Goes FS, Locke AE, Palmer D, Wang W, Cohen-Woods S, et al. Investigating rare pathogenic/likely pathogenic exonic variation in bipolar disorder. Mol Psychiatry. 2021;26:5239–50.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33483695</ArticleId>
            <ArticleId IdType="pmc">8295400</ArticleId>
            <ArticleId IdType="doi">10.1038/s41380-020-01006-9</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Palmer DS, Howrigan DP, Chapman SB, Adolfsson R, Bass N, Blackwood D, et al. Exome sequencing in bipolar disorder reveals shared risk gene AKAP11 with schizophrenia. MedRxiv. 2021:2021.03.09.21252930.</Citation>
        </Reference>
        <Reference>
          <Citation>Nakajima K, Miranda A, Craig DW, Shekhtman T, Kmoch S, Bleyer A, et al. Ntrk1 mutation co-segregating with bipolar disorder and inherited kidney disease in a multiplex family causes defects in neuronal growth and depression-like behavior in mice. Transl Psychiatry. 2020;10:407.</Citation>
        </Reference>
        <Reference>
          <Citation>Badner JA, Koller D, Foroud T, Edenberg H, Nurnberger JI, Zandi PP, et al. Genome-wide linkage analysis of 972 bipolar pedigrees using single-nucleotide polymorphisms. Mol Psychiatry. 2012;17:818–26.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21769101</ArticleId>
            <ArticleId IdType="doi">10.1038/mp.2011.89</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Glusman G, Caballero J, Mauldin DE, Hood L, Roach JC. Kaviar: an accessible system for testing SNV novelty. Bioinformatics 2011;27:3216–7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21965822</ArticleId>
            <ArticleId IdType="pmc">3208392</ArticleId>
            <ArticleId IdType="doi">10.1093/bioinformatics/btr540</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McLaren W, Gil L, Hunt SE, Riat HS, Ritchie GRS, Thormann A, et al. The Ensembl variant effect predictor. Genome Biol. 2016;17:122.</Citation>
        </Reference>
        <Reference>
          <Citation>Abecasis GR, Auton A, Brooks LD, DePristo MA, Durbin RM, Handsaker RE, et al. An integrated map of genetic variation from 1,092 human genomes. Nature 2012;491:56–65.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23128226</ArticleId>
            <ArticleId IdType="doi">10.1038/nature11632</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kircher M, Witten DM, Jain P, O’Roak BJ, Cooper GM, Shendure J. A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet. 2014;46:310–5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24487276</ArticleId>
            <ArticleId IdType="pmc">3992975</ArticleId>
            <ArticleId IdType="doi">10.1038/ng.2892</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kang HM, Sul JH, Service SK, Zaitlen NA, Kong S-Y, Freimer NB, et al. Variance component model to account for sample structure in genome-wide association studies. Nat Genet. 2010;42:348–54.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20208533</ArticleId>
            <ArticleId IdType="pmc">3092069</ArticleId>
            <ArticleId IdType="doi">10.1038/ng.548</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Roach JC, Glusman G, Smit AFA, Huff CD, Hubley R, Shannon PT, et al. Analysis of genetic inheritance in a family quartet by whole-genome sequencing. Science 2010;328:636–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20220176</ArticleId>
            <ArticleId IdType="pmc">3037280</ArticleId>
            <ArticleId IdType="doi">10.1126/science.1186802</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stittrich A-B, Lehman A, Bodian DL, Ashworth J, Zong Z, Li H, et al. Mutations in NOTCH1 Cause Adams-Oliver syndrome. Am J Hum Genet. 2014;95:275–84.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25132448</ArticleId>
            <ArticleId IdType="pmc">4157158</ArticleId>
            <ArticleId IdType="doi">10.1016/j.ajhg.2014.07.011</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Warde-Farley D, Donaldson SL, Comes O, Zuberi K, Badrawi R, Chao P, et al. The GeneMANIA prediction server: Biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res. 2010;38:W214–20.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20576703</ArticleId>
            <ArticleId IdType="pmc">2896186</ArticleId>
            <ArticleId IdType="doi">10.1093/nar/gkq537</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Csardi G, Nepusz T. The igraph software package for complex network research. InterJournal, Complex Syst. 2006. 2006.</Citation>
        </Reference>
        <Reference>
          <Citation>Kelly ST leiden: R implementation of the Leiden algorithm. R package version 0.3.7. 2020.</Citation>
        </Reference>
        <Reference>
          <Citation>Fleishman SJ, Leaver-Fay A, Corn JE, Strauch E-M, Khare SD, Koga N, et al. RosettaScripts: A scripting language interface to the Rosetta macromolecular modeling suite. PLoS One. 2011;6:e20161.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21731610</ArticleId>
            <ArticleId IdType="pmc">3123292</ArticleId>
            <ArticleId IdType="doi">10.1371/journal.pone.0020161</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, et al. The protein data bank, 1999–. Int. Tables Crystallogr. Vol. F Crystallogr. Biol. Macromol., Springer; 2006.675–84.</Citation>
        </Reference>
        <Reference>
          <Citation>Kawazoe T, Tsuge H, Imagawa T, Aki K, Kuramitsu S, Fukui K. Structural basis of D-DOPA oxidation by D-amino acid oxidase: alternative pathway for dopamine biosynthesis. Biochem Biophys Res Commun. 2007;355:385–91.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17303072</ArticleId>
            <ArticleId IdType="doi">10.1016/j.bbrc.2007.01.181</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sparey T, Abeywickrema P, Almond S, Brandon N, Byrne N, Campbell A, et al. The discovery of fused pyrrole carboxylic acids as novel, potent D-amino acid oxidase (DAO) inhibitors. Bioorg Med Chem Lett. 2008;18:3386–91.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18455394</ArticleId>
            <ArticleId IdType="doi">10.1016/j.bmcl.2008.04.020</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Duplantier AJ, Becker SL, Bohanon MJ, Borzilleri KA, Chrunyk BA, Downs JT, et al. Discovery, SAR, and pharmacokinetics of a novel 3-hydroxyquinolin-2(1H)-one series of potent D-amino acid oxidase (DAAO) inhibitors. J Med Chem. 2009;52:3576–85.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19438227</ArticleId>
            <ArticleId IdType="doi">10.1021/jm900128w</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hondo T, Warizaya M, Niimi T, Namatame I, Yamaguchi T, Nakanishi K, et al. 4-Hydroxypyridazin-3(2H)-one derivatives as novel D-amino acid oxidase inhibitors. J Med Chem. 2013;56:3582–92.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23566269</ArticleId>
            <ArticleId IdType="doi">10.1021/jm400095b</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hopkins SC, Heffernan MLR, Saraswat LD, Bowen CA, Melnick L, Hardy LW, et al. Structural, kinetic, and pharmacodynamic mechanisms of D-amino acid oxidase inhibition by small molecules. J Med Chem. 2013;56:3710–24.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23631755</ArticleId>
            <ArticleId IdType="doi">10.1021/jm4002583</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ashworth J, Bernard B, Reynolds S, Plaisier CL, Shmulevich I, Baliga NS. Structure-based predictions broadly link transcription factor mutations to gene expression changes in cancers. Nucleic Acids Res. 2014;42:12973–83.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25378323</ArticleId>
            <ArticleId IdType="pmc">4245936</ArticleId>
            <ArticleId IdType="doi">10.1093/nar/gku1031</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2− ΔΔCT method. Methods 2001;25:402–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11846609</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jagannath V, Brotzakis ZF, Parrinello M, Walitza S, Grünblatt E. Controversial effects of D-amino acid oxidase activator (DAOA)/G72 on D-amino acid oxidase (DAO) activity in human neuronal, astrocyte and kidney cell lines: the N-methyl D-aspartate (NMDA) receptor hypofunction point of view. Front Mol Neurosci. 2017;10:342.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29114206</ArticleId>
            <ArticleId IdType="pmc">5660716</ArticleId>
            <ArticleId IdType="doi">10.3389/fnmol.2017.00342</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sacchi S, Bernasconi M, Martineau M, Mothet J-P, Ruzzene M, Pilone MS, et al. pLG72 modulates intracellular D-serine levels through its interaction with D-amino acid oxidase: effect on schizophrenia susceptibility. J Biol Chem. 2008;283:22244–56.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18544534</ArticleId>
            <ArticleId IdType="doi">10.1074/jbc.M709153200</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Crawley JN, Paylor R. A proposed test battery and constellations of specific behavioral paradigms to investigate the behavioral phenotypes of transgenic and knockout mice. Horm Behav. 1997;31:197–211.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9213134</ArticleId>
            <ArticleId IdType="doi">10.1006/hbeh.1997.1382</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cryan JF, Mombereau C. In search of a depressed mouse: Utility of models for studying depression-related behavior in genetically modified mice. Mol Psychiatry. 2004;9:326–57.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14743184</ArticleId>
            <ArticleId IdType="doi">10.1038/sj.mp.4001457</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Neely CLC, Pedemonte KA, Boggs KN, Flinn JM. Nest building behavior as an early indicator of behavioral deficits in mice. JoVE. 2019:e60139.</Citation>
        </Reference>
        <Reference>
          <Citation>Deacon RMJ. Assessing nest building in mice. Nat Protoc. 2006;1:1117.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17406392</ArticleId>
            <ArticleId IdType="doi">10.1038/nprot.2006.170</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Seibenhener ML, Wooten MC. Use of the open field maze to measure locomotor and anxiety-like behavior in mice. JoVE. 2015:e52434.</Citation>
        </Reference>
        <Reference>
          <Citation>Walf AA, Frye CA. The use of the elevated plus maze as an assay of anxiety-related behavior in rodents. Nat Protoc. 2007;2:322–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17406592</ArticleId>
            <ArticleId IdType="pmc">3623971</ArticleId>
            <ArticleId IdType="doi">10.1038/nprot.2007.44</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Porsolt RD, Le Pichon M, Jalfre M. Depression: a new animal model sensitive to antidepressant treatments. Nature 1977;266:730–2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">559941</ArticleId>
            <ArticleId IdType="doi">10.1038/266730a0</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Can A, Dao DT, Arad M, Terrillion CE, Piantadosi SC, Gould TD. The mouse forced swim test. JoVE. 2012:e3638.</Citation>
        </Reference>
        <Reference>
          <Citation>Gould TD, O’Donnell KC, Picchini AM, Dow ER, Chen G, Manji HK. Generation and behavioral characterization of β-catenin forebrain-specific conditional knock-out mice. Behav Brain Res. 2008;189:117–25.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18299155</ArticleId>
            <ArticleId IdType="pmc">2676732</ArticleId>
            <ArticleId IdType="doi">10.1016/j.bbr.2007.12.028</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chartoff EH, Heusner CL, Palmiter RD. Dopamine is not required for the hyperlocomotor response to NMDA receptor antagonists. Neuropsychopharmacology 2005;30:1324–33.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15688082</ArticleId>
            <ArticleId IdType="doi">10.1038/sj.npp.1300678</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Terrillion CE, Dao DT, Cachope R, Lobo MK, Puche AC, Cheer JF, et al. Reduced levels of C acna1c attenuate mesolimbic dopamine system function. Genes, Brain Behav. 2017;16:495–505.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/gbb.12371</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu J, Zou H, Strong JA, Yu J, Zhou X, Xie Q, et al. Bimodal effects of MK-801 on locomotion and stereotypy in C57BL/6 mice. Psychopharmacol (Berl). 2005;177:256–63.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00213-004-1944-1</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bray NL, Pimentel H, Melsted P, Pachter L. Near-optimal probabilistic RNA-seq quantification. Nat Biotechnol. 2016;34:525–7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27043002</ArticleId>
            <ArticleId IdType="doi">10.1038/nbt.3519</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Robinson MD, McCarthy DJ, Smyth GK. edgeR: A Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 2010;26:139–40.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19910308</ArticleId>
            <ArticleId IdType="doi">10.1093/bioinformatics/btp616</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen C, Cheng L, Grennan K, Pibiri F, Zhang C, Badner JA, et al. Two gene co-expression modules differentiate psychotics and controls. Mol Psychiatry. 2013;18:1308–14.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23147385</ArticleId>
            <ArticleId IdType="doi">10.1038/mp.2012.146</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Smyth GKG. Limma: linear models for microarray data. Bioinforma. Comput. Biol. Solut. Using R Bioconductor, New York: Springer-Verlag; 2005.397–420.</Citation>
        </Reference>
        <Reference>
          <Citation>Langfelder P, Horvath S. WGCNA: An R package for weighted correlation network analysis. BMC Bioinforma. 2008;9:559.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1471-2105-9-559</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu D, Lim E, Vaillant F, Asselin-Labat ML, Visvader JE, Smyth GK. ROAST: Rotation gene set tests for complex microarray experiments. Bioinformatics 2010;26:2176–82.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20610611</ArticleId>
            <ArticleId IdType="pmc">2922896</ArticleId>
            <ArticleId IdType="doi">10.1093/bioinformatics/btq401</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4:44–57.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nprot.2008.211</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kozareva V, Martin C, Osorno T, Rudolph S, Guo C, Vanderburg C, et al. A transcriptomic atlas of mouse cerebellar cortex comprehensively defines cell types. Nature 2021;598:214–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">34616064</ArticleId>
            <ArticleId IdType="pmc">8494635</ArticleId>
            <ArticleId IdType="doi">10.1038/s41586-021-03220-z</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Butler A, Hoffman P, Smibert P, Papalexi E, Satija R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat Biotechnol. 2018;36:411–20.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29608179</ArticleId>
            <ArticleId IdType="pmc">6700744</ArticleId>
            <ArticleId IdType="doi">10.1038/nbt.4096</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Karczewski KJ, Francioli LC, Tiao G, Cummings BB, Alföldi J, Wang Q, et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature 2020;581:434–43.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32461654</ArticleId>
            <ArticleId IdType="pmc">7334197</ArticleId>
            <ArticleId IdType="doi">10.1038/s41586-020-2308-7</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wright CF, Fitzgerald TW, Jones WD, Clayton S, McRae JF, Van Kogelenberg M, et al. Genetic diagnosis of developmental disorders in the DDD study: A scalable analysis of genome-wide research data. Lancet 2015;385:1305–14.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25529582</ArticleId>
            <ArticleId IdType="pmc">4392068</ArticleId>
            <ArticleId IdType="doi">10.1016/S0140-6736(14)61705-0</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Genovese G, Fromer M, Stahl EA, Ruderfer DM, Chambert K, Landén M, et al. Increased burden of ultra-rare protein-altering variants among 4,877 individuals with schizophrenia. Nat Neurosci. 2016;19:1433–41.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27694994</ArticleId>
            <ArticleId IdType="pmc">5104192</ArticleId>
            <ArticleId IdType="doi">10.1038/nn.4402</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Satterstrom FK, Kosmicki JA, Wang J, Breen MS, De Rubeis S, An JY, et al. Large-Scale Exome Sequencing Study Implicates Both Developmental and Functional Changes in the Neurobiology of Autism. Cell 2020;180:568–.e23.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31981491</ArticleId>
            <ArticleId IdType="pmc">7250485</ArticleId>
            <ArticleId IdType="doi">10.1016/j.cell.2019.12.036</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Singh T, Poterba T, Curtis D, Akil H, Al-Eissa M, Barchas JD, et al. Rare coding variants in ten genes confer substantial risk for schizophrenia. Nature. https://doi.org/10.1038/s41586-022-04556-w 2022.</Citation>
        </Reference>
        <Reference>
          <Citation>O’Dushlaine C, Rossin L, Lee PH, Duncan L, Parikshak NN, Newhouse S, et al. Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways. Nat Neurosci. 2015;18:199–209.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nn.3922</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Park HK, Shishido Y, Ichise-Shishido S, Kawazoe T, Ono K, Iwana S, et al. Potential role for astroglial D-amino acid oxidase in extracellular D-serine metabolism and cytotoxicity. J Biochem. 2006;139:295–304.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16452318</ArticleId>
            <ArticleId IdType="doi">10.1093/jb/mvj036</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oliet SHR, Mothet JP. Regulation of N-methyl-d-aspartate receptors by astrocytic d-serine. Neuroscience 2009;158:275–83.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18358625</ArticleId>
            <ArticleId IdType="doi">10.1016/j.neuroscience.2008.01.071</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Farrell MS, Werge T, Sklar P, Owen MJ, Ophoff RA, O’donovan MC, et al. Evaluating historical candidate genes for schizophrenia. Mol Psychiatry. 2015;20:555–62.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25754081</ArticleId>
            <ArticleId IdType="pmc">4414705</ArticleId>
            <ArticleId IdType="doi">10.1038/mp.2015.16</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hashimoto A, Yoshikawa M, Niwa A, Konno R. Mice lacking D-amino acid oxidase activity display marked attenuation of stereotypy and ataxia induced by MK-801. Brain Res. 2005;1033:210–5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15694926</ArticleId>
            <ArticleId IdType="doi">10.1016/j.brainres.2004.11.031</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yamanaka M, Miyoshi Y, Ohide H, Hamase K, Konno R. D-Amino acids in the brain and mutant rodents lacking D-amino-acid oxidase activity. Amino Acids. 2012;43:1811–21.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22892863</ArticleId>
            <ArticleId IdType="doi">10.1007/s00726-012-1384-x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang M, Ballard ME, Basso AM, Bratcher N, Browman KE, Curzon P, et al. Behavioral characterization of a mutant mouse strain lacking d-amino acid oxidase activity. Behav Brain Res. 2011;217:81–87.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20933022</ArticleId>
            <ArticleId IdType="doi">10.1016/j.bbr.2010.09.030</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Almond SL, Fradley RL, Armstrong EJ, Heavens RB, Rutter AR, Newman RJ, et al. Behavioral and biochemical characterization of a mutant mouse strain lacking d-amino acid oxidase activity and its implications for schizophrenia. Mol Cell Neurosci. 2006;32:324–34.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16843004</ArticleId>
            <ArticleId IdType="doi">10.1016/j.mcn.2006.05.003</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chumakov I, Blumenfeld M, Guerassimenko O, Cavarec L, Palicio M, Abderrahim H, et al. Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia. Proc Natl Acad Sci USA. 2002;99:13675–80.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12364586</ArticleId>
            <ArticleId IdType="pmc">129739</ArticleId>
            <ArticleId IdType="doi">10.1073/pnas.182412499</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shi J, Gershon ES, Liu C. Genetic associations with schizophrenia: meta-analyses of 12 candidate genes. Schizophr Res. 2008;104:96–107.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18715757</ArticleId>
            <ArticleId IdType="pmc">2562556</ArticleId>
            <ArticleId IdType="doi">10.1016/j.schres.2008.06.016</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu Y-L, Wang S-C, Hwu H-G, Fann CS-J, Yang U-C, Yang W-C, et al. Haplotypes of the D-Amino Acid oxidase gene are significantly associated with schizophrenia and its neurocognitive deficits. PLoS One. 2016;11:e0150435.</Citation>
        </Reference>
        <Reference>
          <Citation>Prata D, Breen G, Osborne S, Munro J, St Clair D, Collier D. Association of DAO and G72(DAOA)/G30 genes with bipolar affective disorder. Am J Med Genet B Neuropsychiatr Genet. 2008;147B:914–7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18165970</ArticleId>
            <ArticleId IdType="doi">10.1002/ajmg.b.30682</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bass NJ, Datta SR, McQuillin A, Puri V, Choudhury K, Thirumalai S, et, 74 al. Evidence for the association of the DAOA (G72) gene with schizophrenia and bipolar disorder but not for the association of the DAO gene with schizophrenia. Behav Brain Funct. 2009;5:28.</Citation>
        </Reference>
        <Reference>
          <Citation>Jönsson EG, Saetre P, Vares M, Andreou D, Larsson K, Timm S, et al. DTNBP1, NRG1, DAOA, DAO and GRM3 polymorphisms and schizophrenia: An association study. Neuropsychobiology 2009;59:142–50.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19439994</ArticleId>
            <ArticleId IdType="doi">10.1159/000218076</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Leaver-Fay A, Tyka M, Lewis SM, Lange OF, Thompson J, Jacak R, et al. ROSETTA3: an object-oriented software suite for the simulation and design of macromolecules. Methods Enzymol. 2011;487:545–74.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21187238</ArticleId>
            <ArticleId IdType="pmc">4083816</ArticleId>
            <ArticleId IdType="doi">10.1016/B978-0-12-381270-4.00019-6</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Molla G Competitive inhibitors unveil structure/function relationships in human D-amino acid oxidase. Front Mol Biosci. 2017;4:80.</Citation>
        </Reference>
        <Reference>
          <Citation>Brandish PE, Chiu CS, Schneeweis J, Brandon NJ, Leech CL, Kornienko O, et al. A cell-based ultra-high-throughput screening assay for identifying inhibitors of D-amino acid oxidase. J Biomol Screen. 2006;11:481–7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16760370</ArticleId>
            <ArticleId IdType="doi">10.1177/1087057106288181</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Saunders A, Macosko EZ, Wysoker A, Goldman M, Krienen FM, de Rivera H, et al. Molecular diversity and specializations among the cells of the adult mouse brain. Cell 2018;174:1015–.e16.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30096299</ArticleId>
            <ArticleId IdType="pmc">6447408</ArticleId>
            <ArticleId IdType="doi">10.1016/j.cell.2018.07.028</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sasabe J, Suzuki M, Imanishi N, Aiso S. Activity of D-amino acid oxidase is widespread in the human central nervous system. Front Synaptic Neurosci. 2014;6:14.</Citation>
        </Reference>
        <Reference>
          <Citation>Pritchett D, Hasan S, Tam SKE, Engle SJ, Brandon NJ, Sharp T, et al. d-amino acid oxidase knockout (Dao(-/-)) mice show enhanced short-term memory performance and heightened anxiety, but no sleep or circadian rhythm disruption. Eur J Neurosci. 2015;41:1167–79.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25816902</ArticleId>
            <ArticleId IdType="pmc">4744680</ArticleId>
            <ArticleId IdType="doi">10.1111/ejn.12880</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Morikawa A, Hamase K, Inoue T, Konno R, Niwa A, Zaitsu K. Determination of free D-aspartic acid, D-serine and D-alanine in the brain of mutant mice lacking D-amino acid oxidase activity. J Chromatogr B Biomed Sci Appl. 2001;757:119–25.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11419736</ArticleId>
            <ArticleId IdType="doi">10.1016/S0378-4347(01)00131-1</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Juster RP, McEwen BS, Lupien SJ. Allostatic load biomarkers of chronic stress and impact on health and cognition. Neurosci Biobehav Rev. 2010;35:2–16.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19822172</ArticleId>
            <ArticleId IdType="doi">10.1016/j.neubiorev.2009.10.002</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Post RM, Leverich GS. The role of psychosocial stress in the onset and progression of bipolar disorder and its comorbidities: The need for earlier and alternative modes of therapeutic intervention. Dev Psychopathol. 2006;18:1181–211.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17064434</ArticleId>
            <ArticleId IdType="doi">10.1017/S0954579406060573</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ebner K, Singewald N. Individual differences in stress susceptibility and stress inhibitory mechanisms. Curr Opin Behav Sci. 2017;14:54–64.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cobeha.2016.11.016</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alloy L, Seligman M. On the cognitive component of learned helplessness and depression. Psychol Learn Motiv. 1979;13:219–76.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0079-7421(08)60084-5</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maier SF, Seligman MEP. Learned helplessness at fifty: Insights from neuroscience. 2016;123:349–67.</Citation>
        </Reference>
        <Reference>
          <Citation>Baselmans BML, Jansen R, Ip HF, van Dongen J, Abdellaoui A, van de Weijer MP, et al. Multivariate genome-wide analyses of the well-being spectrum. Nat Genet. 2019;51:445–51.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30643256</ArticleId>
            <ArticleId IdType="doi">10.1038/s41588-018-0320-8</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Luciano M, Hagenaars SP, Davies G, Hill WD, Clarke TK, Shirali M, et al. Association analysis in over 329,000 individuals identifies 116 independent variants influencing neuroticism. Nat Genet. 2018;50:6–11.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29255261</ArticleId>
            <ArticleId IdType="doi">10.1038/s41588-017-0013-8</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Atz ME, Rollins B, Vawter MP. NCAM1 association study of bipolar disorder and schizophrenia: Polymorphisms and alternatively spliced isoforms lead to similarities and differences. Psychiatr Genet. 2007;17:55–67.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17413444</ArticleId>
            <ArticleId IdType="pmc">2077086</ArticleId>
            <ArticleId IdType="doi">10.1097/YPG.0b013e328012d850</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lippard ETC, Nemeroff CB. The devastating clinical consequences of child abuse and neglect: Increased disease vulnerability and poor treatment response in mood disorders. Am J Psychiatry. 2020;177:20–36.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31537091</ArticleId>
            <ArticleId IdType="doi">10.1176/appi.ajp.2019.19010020</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gould TD, Gottesman II. Psychiatric endophenotypes and the development of valid animal models. Genes, Brain Behav. 2006;5:113–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1601-183X.2005.00186.x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lenox RH, Gould TD, Manji HK. Endophenotypes in bipolar disorder. Am J Med Genet - Neuropsychiatr Genet. 2002;114:391–406.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ajmg.10360</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kakegawa W, Miyoshi Y, Hamase K, Matsuda S, Matsuda K, Kohda K, et al. D-Serine regulates cerebellar LTD and motor coordination through the δ glutamate receptor. Nat Neurosci. 2011;14:603–13.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21460832</ArticleId>
            <ArticleId IdType="doi">10.1038/nn.2791</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Naur P, Hansen KB, Kristensen AS, Dravid SM, Pickering DS, Olsen L, et al. Ionotropic glutamate-like receptor δ2 binds D-serine and glycine. Proc Natl Acad Sci USA 2007;104:14116–21.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17715062</ArticleId>
            <ArticleId IdType="pmc">1955790</ArticleId>
            <ArticleId IdType="doi">10.1073/pnas.0703718104</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gao Z, Van Beugen BJ, De Zeeuw CI. Distributed synergistic Plasticity and cerebellar learning. Nat Rev Neurosci. 2012;13:619–35.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22895474</ArticleId>
            <ArticleId IdType="doi">10.1038/nrn3312</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Strata P. The emotional cerebellum. Cerebellum 2015;14:570–7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25626523</ArticleId>
            <ArticleId IdType="doi">10.1007/s12311-015-0649-9</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sacchetti B, Scelfo B, Tempia F, Strata P. Long-term synaptic changes induced in the cerebellar cortex by fear conditioning. Neuron 2004;42:973–82.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15207241</ArticleId>
            <ArticleId IdType="doi">10.1016/j.neuron.2004.05.012</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Han JK, Kwon SH, Kim YG, Choi J, Kim JI, Lee YS, et al. Ablation of STAT3 in purkinje cells reorganizes cerebellar synaptic plasticity in long-term fear memory network. Elife 2021;10:1–23.</Citation>
        </Reference>
        <Reference>
          <Citation>Phillips JR, Hewedi DH, Eissa AM, Moustafa AA. The cerebellum and psychiatric disorders. Front Public Heal. 2015;3:66.</Citation>
        </Reference>
        <Reference>
          <Citation>Wang SSH, Kloth AD, Badura A. The cerebellum, sensitive periods, and autism. Neuron 2014;83:518–32.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25102558</ArticleId>
            <ArticleId IdType="pmc">4135479</ArticleId>
            <ArticleId IdType="doi">10.1016/j.neuron.2014.07.016</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ding S-L, Royall JJ, Sunkin SM, Ng L, Facer BAC, Lesnar P, et al. Comprehensive cellular-resolution atlas of the adult human brain. J Comp Neurol. 2016;524:3127–481.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27418273</ArticleId>
            <ArticleId IdType="pmc">5054943</ArticleId>
            <ArticleId IdType="doi">10.1002/cne.24080</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Delbello MP, Strakowski SM, Zimmerman ME, Hawkins JM, Sax KW. MRI analysis of the cerebellum in bipolar disorder: A pilot study. Neuropsychopharmacology 1999;21:63–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10379520</ArticleId>
            <ArticleId IdType="doi">10.1016/S0893-133X(99)00026-3</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baldaçara L, Nery-Fernandes F, Rocha M, Quarantini LC, Rocha GGL, Guimarães JL, et al. Is cerebellar volume related to bipolar disorder? J Affect Disord. 2011;135:305–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21783257</ArticleId>
            <ArticleId IdType="doi">10.1016/j.jad.2011.06.059</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lupo M, Siciliano L, Leggio M. From cerebellar alterations to mood disorders: A systematic review. Neurosci Biobehav Rev. 2019;103:21–28.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31195001</ArticleId>
            <ArticleId IdType="doi">10.1016/j.neubiorev.2019.06.008</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>He Y, Wang Y, Chang TT, Jia Y, Wang J, Zhong S, et al. Abnormal intrinsic cerebro-cerebellar functional connectivity in un-medicated patients with bipolar disorder and major depressive disorder. Psychopharmacol (Berl). 2018;235:3187–3200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00213-018-5021-6</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Y, Zhong S, Chen G, Liu T, Zhao L, Sun Y, et al. Altered cerebellar functional connectivity in remitted bipolar disorder: A resting-state functional magnetic resonance imaging study. Aust N. Zeal J Psychiatry. 2018;52:52.</Citation>
        </Reference>
        <Reference>
          <Citation>Maloku E, Covelo IR, Hanbauer I, Guidotti A, Kadriu B, Hu Q, et al. Lower number of cerebellar Purkinje neurons in psychosis is associated with reduced reelin expression. Proc Natl Acad Sci USA 2010;107:4407–11.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20150511</ArticleId>
            <ArticleId IdType="pmc">2840121</ArticleId>
            <ArticleId IdType="doi">10.1073/pnas.0914483107</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tran KD, Smutzer GS, Doty RL, Arnold SE. Reduced Purkinje cell size in the cerebellar vermis of elderly patients with schizophrenia. Am J Psychiatry. 1998;155:1288–90.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9734558</ArticleId>
            <ArticleId IdType="doi">10.1176/ajp.155.9.1288</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Skefos J, Cummings C, Enzer K, Holiday J, Weed K, Levy E, et al. Regional alterations in Purkinje cell density in patients with autism. PLoS One. 2014;9:e81255.</Citation>
        </Reference>
        <Reference>
          <Citation>Benes FM, Berretta S. GABAergic interneurons: Implications for understanding schizophrenia and bipolar disorder. Neuropsychopharmacology 2001;25:1–27.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11377916</ArticleId>
            <ArticleId IdType="doi">10.1016/S0893-133X(01)00225-1</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fatemi SH, Folsom TD, Rooney RJ, Thuras PD. Expression of GABAA α2-, β1- and ɛ-receptors are altered significantly in the lateral cerebellum of subjects with schizophrenia, major depression and bipolar disorder. Transl Psychiatry. 2013;3:e303–e303.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24022508</ArticleId>
            <ArticleId IdType="pmc">3784760</ArticleId>
            <ArticleId IdType="doi">10.1038/tp.2013.64</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bullock WM, Cardon K, Bustillo J, Roberts RC, Perrone-Bizzozero NI. Altered expression of genes involved in GABAergic transmission and neuromodulation of granule cell activity in the cerebellum of schizophrenia patients. Am J Psychiatry. 2008;165:1594–603.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18923069</ArticleId>
            <ArticleId IdType="doi">10.1176/appi.ajp.2008.07121845</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lupo M, Olivito G, Siciliano L, Masciullo M, Molinari M, Cercignani M, et al. Evidence of cerebellar involvement in the onset of a manic state. Front Neurol. 2018;9:774.</Citation>
        </Reference>
        <Reference>
          <Citation>Wolf U, Rapoport MJ, Schweizer TA. Evaluating the affective component of the cerebellar cognitive affective syndrome. J Neuropsychiatry Clin Neurosci. 2009;21:245–53.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19776302</ArticleId>
            <ArticleId IdType="doi">10.1176/jnp.2009.21.3.245</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lauterbach EC. Bipolar disorders, dystonia, and compulsion after dysfunction of the cerebellum, dentatorubrothalamic tract, and substantia nigra. Biol Psychiatry. 1996;40:726–30.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8894064</ArticleId>
            <ArticleId IdType="doi">10.1016/0006-3223(96)82516-9</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
